Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $491.07 | 8 | 98.4% |
| Education | $7.82 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| QOL Medical, LLC | $168.44 | 3 | $0 (2018) |
| AbbVie Inc. | $166.56 | 2 | $0 (2021) |
| Circassia Pharmaceuticals Inc | $125.00 | 1 | $0 (2018) |
| Celgene Corporation | $16.13 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $14.94 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $16.13 | 1 | Celgene Corporation ($16.13) |
| 2021 | $69.65 | 1 | AbbVie Inc. ($69.65) |
| 2019 | $104.73 | 2 | AbbVie, Inc. ($96.91) |
| 2018 | $161.61 | 4 | Circassia Pharmaceuticals Inc ($125.00) |
| 2017 | $146.77 | 1 | QOL Medical, LLC ($146.77) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Neuroscience | ||||||
| 10/05/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $69.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $7.82 | General |
| Category: Hepatology | ||||||
| 07/31/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $96.91 | General |
| Category: Immunology | ||||||
| 08/07/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2018 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $9.29 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/18/2018 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 02/21/2018 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $12.38 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/29/2017 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $146.77 | General |
| Category: THERAPY FOR CSID | ||||||
About Dr. Jyoti Sinha, M.D
Dr. Jyoti Sinha, M.D is a Pediatric Gastroenterology healthcare provider based in Warren, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205164134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jyoti Sinha, M.D has received a total of $498.89 in payments from pharmaceutical and medical device companies, with $16.13 received in 2022. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($491.07).
Practice Information
- Specialty Pediatric Gastroenterology
- Location Warren, NJ
- Active Since 12/04/2009
- Last Updated 07/22/2019
- Taxonomy Code 2080P0206X
- Entity Type Individual
- NPI Number 1205164134
Products in Payments
- Sucraid (Drug) $168.44
- NIOX VERO DEVICE (Device) $125.00
- Humira (Biological) $96.91
- HUMIRA (Biological) $69.65
- ZEPOSIA (Drug) $16.13
- TRELEGY ELLIPTA (Drug) $14.94
- (820) Cholbam (Drug) $7.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.